Provided by Tiger Trade Technology Pte. Ltd.

OCUMENSION-B

5.285
-0.030-0.56%
Volume:64.00K
Turnover:338.62K
Market Cap:4.31B
PE:-22.65
High:5.340
Open:5.320
Low:5.270
Close:5.315
52wk High:12.070
52wk Low:4.040
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:0.18
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.233
ROE:-4.26%
ROA:-2.48%
PB:1.00
PE(LYR):-22.65
PS:4.59

Loading ...

Ascletis Pharma-B Warns of 263.5% Surge in Interim Loss to Roughly RMB 319.7 Million

Stock News
·
Aug 21

Huiyu Pharma's Aesthetic Medicine Expansion Stalls: Subsidiary Insolvency and Funding Model Expose Multiple Hazards

Deep News
·
Aug 21

Historic mRNA Cancer Vaccine Breakthrough Sends Pharmaceutical Stocks Soaring on US, A-share, and HK Markets

Deep News
·
Aug 20

BAIYUNSHAN PH Secures Regulatory Approval for Citicoline Sodium Injection New Dosage Strengths

Stock News
·
Aug 19

Penalty Finalized for Nanxin Pharmaceutical Over Disclosure Violations, Affected Investors Invited to Register Claims

Deep News
·
Aug 19

China's AI-Driven Drug Discovery Sector Poised for Clinical Breakthroughs and Commercial Growth, Analyst Says

Stock News
·
Aug 19

Zejing Pharma Seeks Hong Kong Listing After Turning Profitable, But Earnings Quality Raises Questions

Deep News
·
Aug 17

17 Drugmakers Announce Major Executive Reshuffles in Half a Month

Deep News
·
Aug 17

BAIYUNSHAN PH Subsidiary Secures Pharmaceutical Registration Certificate from Macau Health Regulator

Stock News
·
Aug 17

Fictitious Profits Equated to 157% of Total Reported Income: A 2023 Loss Was Masked as Gains for This Company, Affected Investors May Be Eligible for Claims

Deep News
·
Aug 17

Penalty on Nanyangxin Pharmaceutical Fuels Ongoing Investor Claims

Deep News
·
Aug 14

Ocumension Therapeutics Sets 28 August Board Meeting to Review 1H 2026 Results and Potential Interim Dividend

Bulletin Express
·
Aug 14

Ocumension Therapeutics Schedules Board Meeting to Review Interim Results, Consider Dividend

Reuters
·
Aug 14

Zelgen Biopharma Makes Second Attempt at Hong Kong IPO Amid Insider Selling and Related-Party Acquisition Concerns

Deep News
·
Aug 14

Listing Update: Suzhou Zelgen Biopharmaceuticals Files Again for Hong Kong IPO

Stock News
·
Aug 13

Hong Kong Stock Movers: METIS TECHBIO-P Surges Over 7% Again, Accumulating Nearly 30% Gains Since Early August, Leading AI Drug Discovery Sector for Consecutive Days

Stock News
·
Aug 11

Ascletis-B Launches Two Phase 1 Obesity Studies in the United States

Stock News
·
Aug 10

AI-Driven Drug Discovery Nears Reality: From Molecule Generation to Clinical Validation

Deep News
·
Aug 10

AI Drug Discovery Sparks 'Tool Seller' Surge, CXO Giants Break Multiple Records! Innovative Drugs Next in Line? Fund Manager's Latest Analysis!

Deep News
·
Aug 10

Sichuan Huiyu Pharmaceutical Secures European Marketing Approvals for Two Injectable Drugs

Stock News
·
Aug 10